Cindy‐ann Tompkins

RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis

Ikuo Hirano, Margaret H. Collins, Yehudith Assouline-Dayan et al. · Gastroenterology · 2018 · 258 citations · Full text

Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial

Robert P. Frantz, Vallerie V. McLaughlin, Sandeep Sahay et al. · The Lancet Respiratory Medicine · 2024 · 51 citations

Placebo-controlled Phase 2, Hypertension, Pulmonary Arterial Hypertension +11

Effects of High‐ and Low‐Fat Meals on the Pharmacokinetics of Ozanimod, a Novel Sphingosine‐1‐Phosphate Receptor Modulator

Jonathan Q. Tran, Jeffrey Hartung, Cindy‐ann Tompkins et al. · Clinical Pharmacology in Drug Development · 2017 · 26 citations · Full text

A Randomized, Double-Blind, Placebo-Controlled Trial of a Novel Recombinant, Humanized, Anti-Interleukin-13 Monoclonal Antibody (RPC4046) in Patients with Active Eosinophilic Esophagitis: Results of the HEROES Study

Evan S. Dellon, Margaret H. Collins, Yehudith Assouline-Dayan et al. · The American Journal of Gastroenterology · 2016 · 20 citations

Clinical Immunology, Immunodeficiencies, Immunology +18

A phase 2 study to evaluate the safety, efficacy and pharmacokinetics of DP2 antagonist GB001 and to explore biomarkers of airway inflammation in mild‐to‐moderate asthma

Héctor Ortega, Mary Fitzgerald, Kartik Raghupathi et al. · Clinical & Experimental Allergy · 2019 · 16 citations · Full text